Bartolini, E. http://orcid.org/0000-0003-4536-2630
Borgogni, E.
Bruttini, M. http://orcid.org/0000-0003-1063-2522
Muzzi, A.
Giuliani, M.
Iozzi, S.
Petracca, R.
Martinelli, M.
Bonacci, S. http://orcid.org/0000-0002-7771-4736
Marchi, S.
Brettoni, C.
Donati, C.
Torricelli, G.
Guidotti, S.
Domina, M.
Beninati, C. http://orcid.org/0000-0001-8305-1337
Teti, G.
Felici, F. http://orcid.org/0000-0003-2205-5195
Rappuoli, R. http://orcid.org/0000-0002-8827-254X
Castellino, F.
Del Giudice, G.
Masignani, V.
Pizza, M.
Maione, D. http://orcid.org/0000-0002-8441-9241
Article History
Received: 13 November 2019
Accepted: 10 September 2020
First Online: 5 October 2020
Competing Interests
: This study was sponsored by Novartis Vaccines, now acquired by the GSK group of companies. All authors have declared the following interests: E. Ba, E. Bo, A.M., M.G., S.I., R.P., M.M., S.B., S.M., C. Br, C.D., G. To, S.G., R.R., F.C., G.D.G., V.M., M.P. and D.M. were permanent employees of Novartis Vaccines at the time of the study. M.B. was holding a PhD studentship and collaborated with GSK at the time of the study as part of his PhD training. Following the acquisition of Novartis Vaccines by the GSK group of companies in March, 2015, E. Ba, E. Bo, A.M., M.G., S.I., R.P., S.B., S.M., C. Br, G. To, S.G., R.R., G.D.G., V.M., M.P. and D.M. are now permanent employees of the GSK group of companies. M.B. is now permanent employee of Polo GGB. C.D. is now permanent employee of Fondazione Edmund Mach, San Michele all’Adige. C. Be and G. Te are Professors, and M.D. was holding a PhD studentship at the time of the study, at the University of Messina. F.F. is Professor at the University of Molise. F.C. is now permanent employee of US Department of Health & Human services. G.D.G. own shares and stock options of the GSK group of companies.